{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:16:46Z","timestamp":1789881406701,"version":"4.0.1"},"reference-count":49,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T00:00:00Z","timestamp":1448841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T00:00:00Z","timestamp":1448841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"JSPS KAKENHI Grant"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostate"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1002\/pros.23129","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T07:26:49Z","timestamp":1448868409000},"page":"376-382","source":"Crossref","is-referenced-by-count":10,"title":["Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-na\u00efve prostate cancer"],"prefix":"10.1002","volume":"76","author":[{"given":"Yasuhide","family":"Miyoshi","sequence":"first","affiliation":[{"name":"Department of Urology; Yokohama City University Graduate School of Medicine; Yokohama Japan"},{"name":"Department of Urology and Renal Transplantation; Yokohama City University Medical Center; Yokohama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroji","family":"Uemura","sequence":"additional","affiliation":[{"name":"Department of Urology; Yokohama City University Graduate School of Medicine; Yokohama Japan"},{"name":"Department of Urology and Renal Transplantation; Yokohama City University Medical Center; Yokohama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Umemoto","sequence":"additional","affiliation":[{"name":"Department of Urology; Yokohama City University Graduate School of Medicine; Yokohama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Sakamaki","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology; Yokohama City University, Graduate School of Medicine; Yokohama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Taguri","sequence":"additional","affiliation":[{"name":"Department of Urology and Renal Transplantation; Yokohama City University Medical Center; Yokohama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Urology; Gunma University Graduate School of Medicine; Maebashi Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Urology; Gunma University Graduate School of Medicine; Maebashi Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Masumori","sequence":"additional","affiliation":[{"name":"Department of Urologic Surgery and Andrology; Sapporo Medical University School of Medicine; Sapporo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Department of Urology; Chiba University Graduate School of Medicine; Chiba Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Mizokami","sequence":"additional","affiliation":[{"name":"Department of Integrative Cancer Therapy and Urology; Kanazawa University Graduate School of Medical Science; Kanazawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Sugimura","sequence":"additional","affiliation":[{"name":"Department of Nephro-Urologic Surgery and Andrology; Mie University Graduate School of Medicine; Tsu Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Nonomura","sequence":"additional","affiliation":[{"name":"Department of Urology; Osaka University Graduate School of Medicine; Osaka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Nephro-Urology; Nagasaki University Graduate School of Biomedical Sciences; Nagasaki Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seijiro","family":"Honma","sequence":"additional","affiliation":[{"name":"Department of Analytical Research; ASKA Pharma Medical Co. Ltd.; Kawasaki Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaoki","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Urology and Pathology; Kanagawa Cancer Center, Asahi-ku; Yokohama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kubota","sequence":"additional","affiliation":[{"name":"Department of Urology; Yokohama City University Graduate School of Medicine; Yokohama Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,11,30]]},"reference":[{"issue":"4","key":"10.1002\/pros.23129-BIB0001|pros23129-cit-0001","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jjco\/hyu003","article-title":"Cancer incidence and incidence rates in Japan in 2008: A study of 25 population-based cancer registries for the monitoring of cancer incidence in Japan (MCIJ) project","volume":"44","author":"Matsuda","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"10.1002\/pros.23129-BIB0002|pros23129-cit-0002","first-page":"293","article-title":"Studies on prostatic cancer I: The effect of castration, of estrogen, and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"1","author":"Huggins","year":"1941","journal-title":"Cancer Res"},{"issue":"1","key":"10.1002\/pros.23129-BIB0003|pros23129-cit-0003","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1200\/JCO.1997.15.1.382","article-title":"Second-line hormonal therapy for advanced prostate cancer: A shifting paradigm","volume":"15","author":"Small","year":"1997","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1002\/pros.23129-BIB0004|pros23129-cit-0004","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/S0022-5347(01)62501-1","article-title":"Management of hormone refractory prostate cancer: Current standards and future prospects","volume":"160","author":"Oh","year":"1998","journal-title":"J Urol"},{"issue":"1","key":"10.1002\/pros.23129-BIB0005|pros23129-cit-0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0303-7207(85)90138-8","article-title":"Control of secretion and the function of C19-delta 5-steroids of the human adrenal gland","volume":"41","author":"Adams","year":"1985","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"10.1002\/pros.23129-BIB0006|pros23129-cit-0006","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/mend.11.4.9906","article-title":"Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells","volume":"11","author":"Tan","year":"1997","journal-title":"Mol Endocrinol"},{"issue":"13","key":"10.1002\/pros.23129-BIB0007|pros23129-cit-0007","first-page":"3084","article-title":"Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone","volume":"59","author":"Rao","year":"1999","journal-title":"Cancer Res"},{"issue":"4","key":"10.1002\/pros.23129-BIB0008|pros23129-cit-0008","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1677\/ERC-09-0070","article-title":"Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone","volume":"16","author":"Mizokami","year":"2009","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1002\/pros.23129-BIB0009|pros23129-cit-0009","first-page":"5","article-title":"LC-MS\/MS in the clinical laboratory-Where to from here","volume":"32","author":"Grebe","year":"2011","journal-title":"Clin Biochem Rev"},{"issue":"Pt 6","key":"10.1002\/pros.23129-BIB0010|pros23129-cit-0010","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1258\/000456305774538175","article-title":"Development of a method for the measurement of dehydroepiandrosterone sulphate by liquid chromatography-tandem mass spectrometry","volume":"42","author":"Chadwick","year":"2005","journal-title":"Ann Clin Biochem"},{"issue":"3-4","key":"10.1002\/pros.23129-BIB0011|pros23129-cit-0011","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0039-128X(01)00147-7","article-title":"Measurement of steroid sex hormones in serum: A comparison of radioimmunoassay and mass spectrometry","volume":"67","author":"Dorgan","year":"2002","journal-title":"Steroids"},{"key":"10.1002\/pros.23129-BIB0012|pros23129-cit-0012","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cca.2014.08.023","article-title":"Simultaneous measurement of testosterone, androstenedione and dehydroepiandrosterone (DHEA) in serum and plasma using Isotope-Dilution 2-Dimension Ultra High Performance Liquid-Chromatography Tandem Mass Spectrometry (ID-LC-MS\/MS)","volume":"438","author":"Buttler","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1002\/pros.23129-BIB0013|pros23129-cit-0013","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jsbmb.2014.04.002","article-title":"Methodological approach to the intracrine study and estimation of DHEA and DHEA-S using liquid chromatography-tandem mass spectrometry (LC-MS\/MS)","volume":"145","author":"Shibata","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"9","key":"10.1002\/pros.23129-BIB0014|pros23129-cit-0014","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1507\/endocrj.K09E-186","article-title":"Liquid chromatography-tandem mass spectrometry (LC-MS\/MS) assay for simultaneous measurement of salivary testosterone and cortisol in healthy men for utilization in the diagnosis of late-onset hypogonadism in males","volume":"56","author":"Matsui","year":"2009","journal-title":"Endocr J"},{"issue":"3","key":"10.1002\/pros.23129-BIB0015|pros23129-cit-0015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.steroids.2010.12.001","article-title":"Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues","volume":"76","author":"Arai","year":"2011","journal-title":"Steroids"},{"issue":"1","key":"10.1002\/pros.23129-BIB0016|pros23129-cit-0016","first-page":"1","article-title":"Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer","volume":"52","author":"Helzlsouer","year":"1992","journal-title":"Cancer Res"},{"issue":"5","key":"10.1002\/pros.23129-BIB0017|pros23129-cit-0017","first-page":"1366","article-title":"Serum levels of dehydroepiandrosterone and its sulfate and the risk of developing bladder cancer","volume":"51","author":"Gordon","year":"1991","journal-title":"Cancer Res"},{"issue":"1","key":"10.1002\/pros.23129-BIB0018|pros23129-cit-0018","first-page":"33","article-title":"Serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate and the risk of developing gastric cancer","volume":"2","author":"Gordon","year":"1993","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.1002\/pros.23129-BIB0019|pros23129-cit-0019","first-page":"261","article-title":"[Blood levels of dehydroepiandrosterone sulfate (DHEA-S) and the risk of breast cancer]","volume":"306","author":"Gomes","year":"1988","journal-title":"C R Acad Sci III"},{"issue":"3","key":"10.1002\/pros.23129-BIB0020|pros23129-cit-0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/thy.1999.9.285","article-title":"Serum dehydroepiandrosterone sulfate concentration and thyroid cancer risk: A matched case control study","volume":"9","author":"Berg","year":"1999","journal-title":"Thyroid"},{"issue":"20","key":"10.1002\/pros.23129-BIB0021|pros23129-cit-0021","first-page":"6571","article-title":"Dehydroepiandrosterone sulfate and breast cancer risk","volume":"50","author":"Barrett-Connor","year":"1990","journal-title":"Cancer Res"},{"issue":"3","key":"10.1002\/pros.23129-BIB0022|pros23129-cit-0022","first-page":"219","article-title":"The relationship of serum dehydroepiandrosterone and its sulfate to subsequent cancer of the prostate","volume":"2","author":"Comstock","year":"1993","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1002\/pros.23129-BIB0023|pros23129-cit-0023","first-page":"655","article-title":"Seasonal variation in vitamin D, vitamin D-binding protein, and dehydroepiandrosterone: Risk of prostate cancer in black and white men","volume":"4","author":"Corder","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"10.1002\/pros.23129-BIB0024|pros23129-cit-0024","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.juro.2011.05.082","article-title":"High incidence of predominant Gleason pattern 4 localized prostate cancer is associated with low serum testosterone","volume":"186","author":"Botto","year":"2011","journal-title":"J Urol"},{"issue":"11 Pt B","key":"10.1002\/pros.23129-BIB0025|pros23129-cit-0025","first-page":"14","article-title":"Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: Data from ethnic Chinese patients with localized prostate cancer","volume":"110","author":"Dai","year":"2012","journal-title":"BJU Int"},{"issue":"9","key":"10.1002\/pros.23129-BIB0026|pros23129-cit-0026","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1038\/bjc.2014.189","article-title":"Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer","volume":"110","author":"de Liano","year":"2014","journal-title":"Br J Cancer"},{"issue":"6 Pt B","key":"10.1002\/pros.23129-BIB0027|pros23129-cit-0027","first-page":"18","article-title":"Low testosterone level predicts prostate cancer in re-biopsy in patients with high grade prostatic intraepithelial neoplasia","volume":"110","author":"Garcia-Cruz","year":"2012","journal-title":"BJU Int"},{"issue":"4C","key":"10.1002\/pros.23129-BIB0028|pros23129-cit-0028","first-page":"2487","article-title":"Development of a nomogram for predicting high-grade prostate cancer on biopsy: The significance of serum testosterone levels","volume":"28","author":"Ide","year":"2008","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1002\/pros.23129-BIB0029|pros23129-cit-0029","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.eururo.2004.11.003","article-title":"Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy","volume":"47","author":"Imamoto","year":"2005","journal-title":"Eur Urol"},{"issue":"1","key":"10.1002\/pros.23129-BIB0030|pros23129-cit-0030","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/pcan.2008.35","article-title":"Does presence of prostate cancer affect serum testosterone levels in clinically localized prostate cancer patients","volume":"12","author":"Imamoto","year":"2009","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"10.1002\/pros.23129-BIB0031|pros23129-cit-0031","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1442-2042.2008.02074.x","article-title":"The role of testosterone in the pathogenesis of prostate cancer","volume":"15","author":"Imamoto","year":"2008","journal-title":"Int J Urol"},{"issue":"1","key":"10.1002\/pros.23129-BIB0032|pros23129-cit-0032","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.eururo.2013.08.015","article-title":"A new era of testosterone and prostate cancer: From physiology to clinical implications","volume":"65","author":"Khera","year":"2014","journal-title":"Eur Urology"},{"issue":"2","key":"10.1002\/pros.23129-BIB0033|pros23129-cit-0033","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/bju.12739","article-title":"The importance of knowing testosterone levels in patients with prostate cancer","volume":"114","author":"Kirby","year":"2014","journal-title":"BJU Int"},{"issue":"5","key":"10.1002\/pros.23129-BIB0034|pros23129-cit-0034","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/01.ju.0000062674.43964.d0","article-title":"Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy","volume":"169","author":"Massengill","year":"2003","journal-title":"J Urol"},{"issue":"5","key":"10.1002\/pros.23129-BIB0035|pros23129-cit-0035","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.eururo.2006.06.034","article-title":"Testosterone and prostate cancer: An historical perspective on a modern myth","volume":"50","author":"Morgentaler","year":"2006","journal-title":"Eur Urol"},{"issue":"2","key":"10.1002\/pros.23129-BIB0036|pros23129-cit-0036","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.eururo.2008.09.024","article-title":"Shifting the paradigm of testosterone and prostate cancer: The saturation model and the limits of androgen-dependent growth","volume":"55","author":"Morgentaler","year":"2009","journal-title":"Eur Urol"},{"issue":"4","key":"10.1002\/pros.23129-BIB0037|pros23129-cit-0037","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1464-410X.2009.08761.x","article-title":"Evaluation of the serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk","volume":"105","author":"Morote","year":"2010","journal-title":"BJU Int"},{"issue":"5","key":"10.1002\/pros.23129-BIB0038|pros23129-cit-0038","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.eururo.2012.05.025","article-title":"Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial","volume":"62","author":"Muller","year":"2012","journal-title":"Eur Urol"},{"key":"10.1002\/pros.23129-BIB0039|pros23129-cit-0039","article-title":"Low testosterone level is an independent risk factor for high-grade prostate cancer detection at biopsy","author":"Park","year":"2015","journal-title":"BJU Int"},{"issue":"5","key":"10.1002\/pros.23129-BIB0040|pros23129-cit-0040","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1464-410X.2009.08814.x","article-title":"Testosterone levels in patients with metastatic prostate cancer treated with luteinizing hormone-releasing hormone therapy: Prognostic significance","volume":"105","author":"Perachino","year":"2010","journal-title":"BJU Int"},{"issue":"6","key":"10.1002\/pros.23129-BIB0041|pros23129-cit-0041","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1464-410X.2009.08853.x","article-title":"Serum testosterone is associated with aggressive prostate cancer in older men: Results from the Baltimore Longitudinal Study of Aging","volume":"105","author":"Pierorazio","year":"2010","journal-title":"BJU Int"},{"issue":"5","key":"10.1002\/pros.23129-BIB0042|pros23129-cit-0042","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.juro.2008.01.045","article-title":"The ratio of serum testosterone-to-prostate specific antigen predicts prostate cancer in hypogonadal men","volume":"179","author":"Rhoden","year":"2008","journal-title":"J Urol"},{"issue":"4","key":"10.1002\/pros.23129-BIB0043|pros23129-cit-0043","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1464-410X.2011.10335.x","article-title":"Serum testosterone level as a predictor of biochemical failure after radical prostatectomy for localized prostate cancer","volume":"109","author":"Roder","year":"2012","journal-title":"BJU Int"},{"issue":"5","key":"10.1002\/pros.23129-BIB0044|pros23129-cit-0044","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.eururo.2014.08.033","article-title":"Androgen deprivation therapy in prostate cancer: Looking beyond prostate-specific antigen and testosterone levels","volume":"67","author":"Saad","year":"2015","journal-title":"Eur Urol"},{"issue":"4","key":"10.1002\/pros.23129-BIB0045|pros23129-cit-0045","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0022-5347(05)00680-4","article-title":"Low age adjusted free testosterone levels correlate with poorly differentiated prostate cancer","volume":"175","author":"San Francisco","year":"2006","journal-title":"J Urol"},{"issue":"2","key":"10.1002\/pros.23129-BIB0046|pros23129-cit-0046","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00345-012-0902-5","article-title":"Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer","volume":"31","author":"Schnoeller","year":"2013","journal-title":"World J Urol"},{"issue":"1","key":"10.1002\/pros.23129-BIB0047|pros23129-cit-0047","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.eururo.2010.04.001","article-title":"Testosterone measurement in patients with prostate cancer","volume":"58","author":"Schulman","year":"2010","journal-title":"Eur Urol"},{"issue":"8","key":"10.1002\/pros.23129-BIB0048|pros23129-cit-0048","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1373\/49.8.1381","article-title":"Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children","volume":"49","author":"Taieb","year":"2003","journal-title":"Clin Chem"},{"issue":"5","key":"10.1002\/pros.23129-BIB0049|pros23129-cit-0049","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1158\/1055-9965.EPI-06-0792","article-title":"Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry","volume":"16","author":"Hsing","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.23129","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.23129","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pros.23129\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T08:50:19Z","timestamp":1596876619000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/pros.23129"}},"subtitle":["DHEA and Prognosis of Prostate Cancer"],"short-title":[],"issued":{"date-parts":[[2015,11,30]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,3]]}},"URL":"https:\/\/doi.org\/10.1002\/pros.23129","archive":["Portico"],"relation":{},"ISSN":["0270-4137"],"issn-type":[{"value":"0270-4137","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11,30]]}}}